Harrow and iOR Partners expand national product supply agreement
November 30, 2022
The deal will provide Harrow’s entire formulary compounded ophthalmic products to iOR Partners’ expanding office-based surgery locations across the United States.
© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
IOL
Visual outcomes after secondary IOL implantation in aphakic children
December 01, 2022
According to physicians, patients who do not undergo second procedure are more likely to develop glaucoma.
Patricia Piers, PhD, discusses a career of innovation in ophthalmology, looks to future
November 28, 2022
In a two-decade career as a researcher at Johnson & Johnson Surgical Vision, Piers has been a part of teams at the forefront of a number of innovations in IOLs. She discusses her career and the outlook for research and development in ophthalmology.
SBL-3 multifocal IOL offers exceptional vision at all distances
November 23, 2022
The SBL-3 ClearView clinical study, an FDA investigational device exemption clinical trial conducted at 18 sites across the US, is a prospective, subject-masked, randomized, two-arm study.
Alcon completes acquisition of Aerie Pharmaceuticals
November 22, 2022
The deal adds pharmaceutical research and development capabilities and further expertise for future product pipeline. It also expands Alcon’s presence in the $20 billion global ophthalmic pharmaceutical category.
BLOG: Being the change we want to see in ophthalmology
November 22, 2022
A recent study showed that only 6% of practicing ophthalmologists in the US identify as an underrepresented minority.
Boarding Orbis Flying Eye Hospital: Not your typical flight experience
November 16, 2022
When it is not on a mission, the Orbis Flying Eye Hospital MD-10 aircraft often is situated at an airport where the fully accredited teaching facility is put to use as a mobile simulation center to train ophthalmologists from around the world in some of the latest sight-saving techniques.
CMS’ physician fee schedule could have adverse impact on ophthalmologists
November 04, 2022
Medicare’s 2023 fee schedule includes cuts in reimbursement, which some groups say could lead to reduced access to care to patients who need it most.
Avoiding capsule tears with OVDs and PECS
November 03, 2022
OVDs that are currently used in cataract surgery fit into different classes including higher viscosity cohesives, lower viscosity dispersives, viscoadaptives and higher viscosity dispersives.
Private practice vs academics: What do young ophthalmologists need to know?
November 02, 2022
Nicole Bajic, MD, and Neel S. Vaidya, MD, MPH, share their insights from when they were at this crossroads. Learn more clinical pearls on topics like this and more at Real World Ophthalmology’s virtual conference, “Top 10 Things I Wish I Knew Sooner,” this Saturday, November 5.